Accuracy verification of IR Tracking with the Vero4DRT 1 Abstract Purpose: To verify the accuracy of an infrared (IR) marker-based dynamic tumor-tracking irradiation system (IR Tracking) using the gimbaled x-ray head of the Vero4DRT 35 (MHI-TM2000). Methods and Materials: The gimbaled 6-MV C-band x-ray head of the Vero4DRT can swing along the pan-and-tilt direction to track a moving target. During beam delivery, the Vero4DRT predicts the future three-dimensional (3D) target position in real time using a correlation model (4D model) between the target and IR marker motion, and then 40 continuously transfers the corresponding tracking orientation to the gimbaled x-ray head. The 4D-modeling error (E 4DM ) and the positional tracking error (E P ) were defined as the difference between the predicted and measured positions of the target in 4D modeling and as the difference between the tracked and measured positions of the target during irradiation, respectively. For the clinical application of IR Tracking, we assessed the relationship between 45 E 4DM and E P for three 1D sinusoidal (peak-to-peak amplitude [A]: 20-40 mm, breathing period [T]: 2-4 s), five 1D phase-shifted sinusoidal (A: 20 mm, T: 4 s, phase shift [τ]: 0.2-2 s), and six 3D patient respiratory patterns. Results: The difference between the 95 th percentile of the absolute E P ( 95 P E ) and the mean (μ) + two standard deviations (SD) of absolute E 4DM ( SD DM E 2 μ 4 + ) was within ±1 mm for all motion 50 patterns. As the absolute correlation between the target and IR marker motions decreased from 1.0 to 0.1 for the 1D phase-shifted sinusoidal patterns, the SD DM E 2 μ 4 + and 95 P E increased linearly, from 0.4 to 3.0 mm (R = -0.98) and from 0.5 to 2.2 mm (R = -0.95), respectively. There was a strong positive correlation between SD DM E 2 μ 4 + and 95 P E in each direction [(lateral, craniocaudal, anteroposterior) = (0.99, 0.98, 1.00)], even for the 3D respiratory patterns; thus, 95 P E was 55 readily estimated from SD DM E 2 μ 4 + . Conclusions: Positional tracking errors correlated strongly with 4D-modeling errors in IR Accuracy verification of IR Tracking with the Vero4DRT 2 Tracking. Thus, the accuracy of the 4D model must be verified before treatment, and margins are required to compensate for the 4D-modeling error. 60
I. INTRODUCTION
The International Commission on Radiation Units and Measurements (ICRU) 65 recommends that the planning target volume (PTV) includes margins around a clinical target volume (CTV) to account for patient motion, tumor motion, and deformation due to respiration and uncertainties in beam placement. 1, 2 Particularly for thoracic and abdominal tumors, respiration is an important factor causing uncertainty during beam delivery. Several techniques, including respiratory gating, breath-holding, and dynamic tumor tracking (DTT), 70 have been proposed to reduce the uncertainties caused by respiratory motion. 3 Among these techniques, DTT can minimize the internal uncertainties without a prolonged treatment time or the burden of breath-holding for patients. There are two approaches to DTT: direct and indirect methods. 3, 4 While direct methods detect the target itself, indirect methods assess some surrogate quantity and deduce localization information based on the surrogate. 75
We have developed a novel four-dimensional (4D) image-guided radiotherapy system with a DTT function: the Vero4DRT (MHI-TM2000; Mitsubishi Heavy Industries, Ltd., Japan, and BrainLAB, Feldkirchen, Germany). [5] [6] [7] [8] [9] [10] [11] Figure 1 shows a schematic diagram of the Vero4DRT. The Vero4DRT has several unique components that facilitate DTT irradiation: (1) a compact C-band 6-MV x-ray head with a gimbal mechanism, mounted on an O-ring gantry. 80
The gimbaled x-ray head can rotate in both the pan (horizontal to the O-ring) and tilt (vertical to the O-ring) directions, (2) a gantry-mounted orthogonal kV x-ray imaging subsystem, consisting of two sets of x-ray tubes and flat-panel detectors, with a spatial resolution of 0.2 mm at the isocenter level, and (3) an extended version of the ExacTRAC system for the DTT function (BrainLAB) 12, 13 with an infrared (IR) camera mounted on the ceiling of the treatment 85 room.
The Vero4DRT is capable of direct and indirect DTT approaches. One is an x-ray image-based direct DTT approach (X-ray Tracking). 9, 10 A moving tumor is tracked in real time by either direct monitoring of the tumor itself or fiducial markers, using the kV x-ray imaging subsystem. However, the x-ray monitoring interval and image processing time delay cause 90 prediction errors. 10 Furthermore, continuous x-ray monitoring may result in two potential health hazards: deterministic and stochastic risks associated with the increased radiation dose delivered by the kV x-ray imaging subsystem. [14] [15] [16] [17] The other is an IR marker-based indirect DTT approach (IR Tracking), which is available clinically. An advantage of IR Tracking is a substantial reduction in imaging dose, compared with that of X-ray Tracking. During beam 95 delivery, the Vero4DRT monitors the displacement of the IR markers on the abdominal wall continuously via the IR camera of the ExacTRAC system, and then tracks target motion using a correlation model (4D model) between the target and IR marker motions, as described in Section II. A.
A key issue in indirect DTT is the accuracy of the model predicting the internal target 100 position based on the surrogate measurements. 3, 4 Several investigators have shown that the Synchrony Respiratory Tracking System, part of the Cyberknife indirect DTT system (Accuracy Inc., Sunnyvale, CA), was able to follow a moving tumor with high accuracy. [18] [19] [20] [21] [22] Depuydt et al. verified the positional tracking accuracy of IR Tracking only under conditions of a perfect correlation between the target and IR marker motions using a prototype of the 105 Vero4DRT; 13 however, no dosimetric verification was performed. According to the report of the American Association of Physicists in Medicine Task Group 76, phase shifts between the internal tumor and external surrogate motion of > 1 s were observed in patients with lung cancer. 3 The accuracy of a 4D model is unknown in the presence of such a phase shift.
Additionally, tracking accuracy -based on the respiratory tumor and abdominal wall motions 110 of real patients -should be verified before the clinical use of IR Tracking. Thus, in the present study, we verified the dosimetric and positional accuracy of IR Tracking. Figure 2 shows a schematic diagram of IR Tracking. Before irradiation, IR marker displacements on the abdominal wall and the implanted fiducial markers' motion are monitored to create a 4D model for 20-40 s using the IR camera of the ExacTRAC system every 16.7 ms and the orthogonal kV x-ray imaging subsystem every 80 ms, using a 120 stereovision technique. After monitoring, two target positions are determined: the detected target position and the predicted target position. The detected target position is indicated by the centroid of the polyhedron, composed from the implanted fiducial markers. The predicted target position is calculated from the 4D model, expressed by a quadratic equation involving two variables, the position and velocity of the IR markers. In the 4D-modeling phase, the 125 peak-to-peak amplitude of the detected target motion (A) and the mean (μ) and standard deviation (SD) of the absolute difference between the detected and predicted target positions are automatically calculated along each axis ( Fig. 2 ). During beam delivery, the 3D target position is calculated from the displacements of the IR markers using the 4D model, and then the corresponding tracking orientation is transferred continuously to the gimbaled x-ray head. 130
II. MATERIALS AND METHODS 115

II. A. The 4D model for IR Tracking with the Vero4DRT
The predicted target position can also be monitored visually in real time at a minimum interval of 1 s on intra-fractional fluoroscopic images.
II. B. Dosimetric and positional verification of IR Tracking
For the clinical application of IR Tracking, the following verifications were 135 performed:
(1) Dosimetric and positional verification of 1D sinusoidal patterns with perfect correlation between the target and IR marker motions, using a motor-driven base.
Accuracy verification of IR Tracking with the Vero4DRT 4 (2) Positional verification of 1D sinusoidal patterns with miscorrelation between the target and IR marker motions, using a dynamic anthropomorphic thorax phantom. 140
(3) Positional verification of 3D target and 1D surrogate motions, based on the patient's respiration, using a four-axis moving phantom. ), sin(
II. B. 1. Dosimetric and positional verification of IR Tracking for 1D sinusoidal patterns
where y p (t) is the phantom position in the CC direction and z s (t) is the displacement of the IR markers in the AP direction. Positional accuracy was evaluated using the dynamic anthropomorphic thorax phantom (CIRS Inc., Norfolk, VA) with a high precision (0.1 mm) laser displacement gauge. 95 P E was estimated as described in Section II. B. 1. 185 Ontario, Canada) and fiducial markers for measurement using the gantry-mounted orthogonal kV x-ray imaging subsystem were attached to the surface of a cubic phantom. The Polaris Spectra was used for independent validation of IR Tracking and was not part of the Vero4DRT IR Tracking system. Then, the cubic phantom was placed firmly on the 3D-driven base of a four-axis moving phantom, which moved three-dimensionally, based on the acquired internal 195 target motions. Other IR markers for IR Tracking were also placed on the 1D driven base of the four-axis moving phantom, which moved based on the acquired IR marker motions in the AP direction only. The four-axis moving phantom was able to reproduce patient respiratory motions with high precision (0.1 mm). 23 The positions of the IR markers for measurement (P mP [x mP , y mP , z mP ]) and fiducial markers for measurement (P mX [x mX , y mX , z mX ]) were measured 200 with the Polaris Spectra, with a measurement accuracy of 0.3 mm, every 16.7 ms, and by the gantry-mounted orthogonal kV x-ray imaging subsystem every 1 s, respectively. In the present study, these positional data were recorded synchronously, based on the exposer signal of the orthogonal kV x-ray imaging subsystem.
II. B. 3. Positional verification of IR Tracking for 3D respiratory patterns
First, the detection accuracy of the gantry-mounted orthogonal kV x-ray imaging 205 subsystem was evaluated in the stationary condition using the treatment couch, with a positional accuracy of 0.01 mm. Second, in total, 742 comparisons between P mP and P mX were made to evaluate the detection accuracy of the gantry-mounted orthogonal kV x-ray imaging subsystem in the moving condition using the Polaris Spectra and the four-axis moving phantom. 210
To investigate the tracking accuracy in each direction, positional verification was performed at gantry angles of 0° and 90°. Based on the recorded tracking orientation of the gimbaled x-ray head, the tracked position of the target was estimated on the perpendicular plane to the home gimbal-axis at the measured target position. 10 
III. RESULTS AND DISCUSSION 230
III. A. Dosimetric and positional verification of IR Tracking for 1D sinusoidal patterns
III. B. Positional verification of IR Tracking for 1D phase-shifted sinusoidal patterns
III. C. Positional verification of IR Tracking for 3D respiratory patterns
The root mean squares (RMSs) of the detection accuracy of the gantry-mounted orthogonal kV x-ray imaging subsystem under the stationary condition were 0.07, 0.04, and 0.03 mm in the LR, CC, and AP directions, respectively. The RMSs of the detection accuracy 265 of the gantry-mounted orthogonal kV x-ray imaging subsystem under the moving condition were 0.14, 0.39, and 0.15 mm in the LR, CC, and AP directions, respectively. These results show that the gantry-mounted orthogonal kV x-ray imaging subsystem of the Vero4DRT had high detection accuracy, even for moving targets. , in each direction at gantry angles of 0° and 90°. The positional tracking errors were larger in the CC direction than in the other directions [ Fig. 6(a) ]. However, the tracking efficiencies were the 280 highest in the CC direction [ Fig. 6(b) ]. Lower tracking efficiencies in other directions than in the CC direction were caused by the small | | target IR R (Table III) . Additionally, tracking accuracy was not degraded by gantry rotation, even at an angle of 90°.
Pepin et al. suggested that a dry-run treatment session prior to treatment planning is required to determine patient-specific margins covering positional tracking error during the 285 treatment when performing DTT with the Synchrony Respiratory Tracking System. 22 The present study revealed that positional tracking errors were near-identical to 4D-modeling errors, derived from miscorrelation between the target and abdominal wall motions, such as the phase shift or irregular respiration. Thus, users of the Vero4DRT should evaluate the accuracy of the 4D model in a dry-run treatment session, and the following should then be discussed, based on 290 the acquired 4D-modeling accuracy: (1) adding margins to compensate for 4D-modeling errors and (2) conducting respiratory coaching to minimize the phase shift. 24 The correlation between tumor and surrogate motion is known to change from treatment planning to treatment delivery. 3, 25, 26 The change in correlation may cause additional tracking errors in IR Tracking; thus, additional margins to compensate for these uncertainties 295 are required, and confirmation of whether the 4D-modeling errors for each fraction are within the margin derived from 4D-modeling errors at treatment planning is recommended.
Additionally, Malinowski et al. reported that an extended treatment time can lead to miscorrelation between the external surrogate and internal tumor motion, due to baseline drift. 27 During irradiation, we can estimate visually the tracking errors in real time from the 300 implanted fiducial markers -or the tumor itself -on the intra-fractional fluoroscopic images.
When these positions deviate systematically from those predicted, due to baseline drift or changes in respiration, remodeling of the 4D model during a treatment fraction is required to perform IR Tracking safely.
305
IV. CONCLUSIONS
We verified the dosimetric and positional accuracy of IR Tracking and confirmed its feasibility in clinical practice. IR Tracking reduced substantially motion-induced marginal blurring in the dose distribution. Additionally, positional tracking errors correlated strongly with 4D-modeling errors, which resulted from miscorrelations between target and IR marker 310 motions. Thus, the accuracy of the 4D model must be verified before treatment, and margins are required to compensate for 4D-modeling errors.
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